FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Cryobank Holdings LLC

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/6/2018 

3. Issuer Name and Ticker or Trading Symbol

Cord Blood America, Inc. [CBAI]

(Last)        (First)        (Middle)

11915 LA GRANGE AVENUE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

LOS ANGELES, CA 90025       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Remarks:
This statement is jointly filed by Cryobank Holdings LLC ("CCB Holdings"), California Cryobank LLC ("CCB") and California Cryobank Stem Cell Services LLC ("FamilyCord" and together with CCB Holdings and CCB, the "Reporting Persons"). On February 6, 2018, Cord Blood America, Inc. (the "Issuer"), FamilyCord and certain shareholders of the Issuer entered into a voting agreement, pursuant to which, among other things, such shareholders granted to FamilyCord an irrevocable voting proxy (the "Proxy") with respect to the 381,052,632 shares of the Issuer's common stock beneficially owned by such shareholders (such shares, collectively, the "Covered Shares"). As a result of the Proxy, the Reporting Persons share voting power with respect to the Covered Shares, but none of the Reporting Persons has, solely or together with each other or with others, investment power with respect to, or pecuniary interest in, any of the Covered Shares. Neither the filing of this statement nor any of its content shall be deemed an admission by any Reporting Person that it is the beneficial owner of any of any equity securities covered by this statement for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose, and each Reporting Person expressly disclaims beneficial ownership of all such securities.
No securities are beneficially owned.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Cryobank Holdings LLC
11915 LA GRANGE AVENUE
LOS ANGELES, CA 90025
X

California Cryobank LLC
11915 LA GRANGE AVENUE
LOS ANGELES, CA 90025
X

California Cryobank Stem Cell Services LLC
11915 LA GRANGE AVENUE
LOS ANGELES, CA 90025
X


Signatures
/s/ Richard Jennings 2/16/2018
** Signature of Reporting Person Date

/s/ Richard Jennings 2/16/2018
** Signature of Reporting Person Date

/s/ Richard Jennings 2/16/2018
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.